Loading
Latest filing published 27 May 2016 for Cerulean Pharma Inc., €2,390.
No signal scores available.
James E. ONeill has a single filing on record, published on 27 May 2016: a share grant of €2,390 in Cerulean Pharma Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration